Industry News

Industry News

It is an exciting time at ARx. We are continuously expanding our team, technologies, and capabilities. Check back for ARx in the news, corporate updates, and where to find us at industry events.

December 10, 2019

Why ARx?

ARx is extremely proud of its employees achieving a record breaking year with the launch of additional FDA approved thin film products. Visit our LinkedIn page to learn […]
July 28, 2019

AAPS PharmSci360

The ARx team is busy in early November. Our R&D and Engineering team are attending AAPS PharmSci360 in San Antonio, TX, November 3-6, 2019. Contact Eric […]
July 28, 2019

CPhI Worldwide

Contact ARx to set up a meeting at the largest pharmaceutical conference in the world, CPhI Worldwide in Frankfurt Germany! November 5-7, 2019. We are available […]
July 1, 2019

Trends in Global Drug Delivery

Being focused on specific dosage forms such as transdermal patches and mucosal thin films allows ARx to understand the trends in development and commercial markets. We […]
October 29, 2018

AAPS Pharm Sci360

ARx is excited to present its poster, “Comparative Permeation Study of A Novel Buprenorphine Transmucosal Dosage Form versus Sublingual Tablet & Buccal Film” at AAPS Pharm […]
July 23, 2018

ARx Demonstrates Ability To Eliminate Toxic Metabolites With Thin Film Technology

ARx partners with Clients to develop novel drug products with specific delivery objectives such as rapid onset, controlled release, and avoidance of the first pass metabolism. […]
July 23, 2018

Dissolution Testing of a Fast-Dissolving Oral Vardenafil Free Base Film

ARx Research Scientist, William Baer, MS presented Dissolution Testing of a Fast-Dissolving Oral Vardenafil Free Base Film at the American Association of Pharmaceutical Scientists Show in […]
July 23, 2018

What is Drug Delivery by Design?

Quality by Design is well known in the pharmaceutical industry. It is the initiative curated by the Food and Drug Administration (FDA) to ensure that the […]
July 23, 2018

ARx Showcases Mucosal Thin Film Drug Delivery at Industry Events

2018 has been busy for ARx thus far. We are proud to have participated in two major industry events, showcasing how our technology advancements are leading […]
January 22, 2018

2017 Year-End Update on FDA Approved Thin Film Products

The US Food and Drug Administration (FDA) approved its last novel drug of 2017, Giaprezaon to increase blood pressure in adults with septic or other distributive […]
February 13, 2017

The Criticality of Adhesive Selection

With over 35 years experience in the transdermal industry, no one understands adhesive selection for transdermal patches better than ARx, LLC. and Adhesives Research Inc.  The criticality […]
February 13, 2017

Mission Dissolvable: Oral Thin Film Technology

Originally published in 2012 by ARx Technical Director, Scott Barnhart, this article speaks to relevant challenges and benefits seen in the drug market today, specifically, the possibilities and benefits of mucosal thin […]
February 3, 2017

Learn about the benefits of ARx Thin Films and Transdermal Patches at Drug Delivery Partnerships 2017

Attend one of the largest global meetings for accelerating drugs to market and lengthening product lifecycles for long term profitability. Schedule a meeting with ARx‘s Business Development Team […]
February 3, 2017

ARx is headed to the big apple for DCAT Week 2017

On March 20th-23rd, the Drug, Chemical, and Associated Technologies Association takes over Midtown East, Manhattan for thousands of business meetings and networking opportunities.  Schedule a meeting with […]